Vasoconstriction

Vasoconstriction is a narrowing of the lumen of blood vessels. It is the opposite of vasodilation. Factors causing vasoconstriction are called vasoconstrictor, also vasopressors or simply pressors. Vasoconstriction usually results in an increase of the blood pressure. Many vasoconstrictors also cause pupil dilation. (From the Wikpedia article Vasoconstriction.)

Download PDF

Recent Publications on Vasoconstriction:
POLYMERIZED BOVINE HEMOGLOBIN CAN IMPROVE SMALL VOLUME RESUSCITATION FROM HEMORRHAGIC SHOCK IN HAMSTERS. Systemic and microvascular hemodynamic responses to hemorrhagic shock...	19th July, 2008	*La Jolla Bioengineering Institute; and daggerDepartment of	Shock. 2008 Jul 16;. DOI Direct Link
Balance between vasoconstriction and enhanced oxygen delivery. BACKGROUND: Hemoglobin (Hb) solutions are potential alternatives to blood...	18th July, 2008	La Jolla Bioengineering Institute and the Department of Bioengineering,	Transfusion. 2008 Jun 27;. DOI Direct Link
Endothelial effects of antihypertensive treatment: focus on irbesartan. The endothelium is characterized by a wide range of important homeostatic...	17th July, 2008	Department of Endocrinology, V Fazzi Hospital Lecce Italy.	Vasc Health Risk Manag. 2008;4(1):89-101.
Diesel exhaust inhalation elicits acute vasoconstriction in vivo. BACKGROUND: Traffic-related air pollution is consistently associated with...	17th July, 2008	Occupational and Environmental Medicine Program, Department of	Environ Health Perspect. 2008 Jul;116(7):937-42. DOI Direct Link
Effect of adrenergic stimulation on cutaneous microcirculation immediately after surgical adventitiectomy in a rat skin flap model. Chronic sympathetic denervation leads to the development of supersentivity...	16th July, 2008	Department of Anesthesia and Intensive Care Medicine, University Hospital,	Microsurgery. 2008 Jul 11;. DOI Direct Link
→View more research publications.

Vasoconstriction Clinical Trials:
Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm	Coronary Vasospasm

Vasoconstriction Patents:
US Patent No.	Title
7367341	Methods and devices for selective disruption of fatty tissue by controlled cooling
7375219	Substituted indole compounds having NOS inhibitory activity
7375227	Quinoline derivatives
7378108	Percutaneous absorption preparation of compound having angiotensin II antagonistic activity
7378250	Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Vasoconstriction scientists - we have details of around 2991 individuals working on Vasoconstriction .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.